FSP 2025 Summer Pathology Conference

AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.

Adaptive Biotech markets the clonoSEQ Assay which measures residual disease in Lymphoid Malignancies, specifically Multiple Myeloma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

APS Medical Billing is a premier billing firm that provides expert billing and practice management solutions to pathology and laboratory practices nationwide. APS’ clients range in size from a single-physician practice to large, multi-site academic departments, reference and independent labs. The scope of our billing services and proven strategies allow APS to effectively bill for professional, technical and global components of anatomic and clinical pathology services. Please visit our website at www.apsmedbill.com.

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. For more information, please visit www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.

Biocare Medical, LLC is an innovator in developing and supplying world class automated immunohistochemistry instrumentation, and the full range of reagents for IHC lab testing. Biocare is the market leader in simultaneous Multiplex IHC tests which provide increased confidence at critical diagnostic decision points, impacting patient therapy while accelerating turnaround time. Biocare’s advanced micro-polymer™ detection enables unsurpassed specificity and sensitivity. PROMARK™ and “mouse on mouse” IHC detection kits are optimized for rat and mouse tissues and feature proprietary blocking and retrieval reagents, resulting in virtually background free IHC staining. The company’s customers include clinical histology laboratories, pharmaceutical companies, CROs, and biotechnology companies as well as academic, government, military, and other non-profit laboratories. Biocare Medical offers an expanding portfolio of integrated products to address the rapidly growing cancer and infectious disease diagnostic and research markets with novel tissue immunohistochemistry and in situ hybridization methods. Biocare medical is headquartered and has manufacturing facilities in California., and has a global distribution network.

Biocartis’ proprietary MDx Idylla™ platform is a rapid fully automated sample-to-result, PCR based system that offers accurate, highly reliable molecular information from virtually any biological sample in virtually any setting.

Blueprint Medicines is a global biopharmaceutical company.

Caris MPI, Inc is a leading next-generation AI TechBio company and precision medicine pioneer actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition. Through comprehensive molecular profiling (DNA, RNA and proteins) and the application of AI and machine learning algorithms, Caris has created the large-scale, multi-modal database and computing capability needed to analyze and unravel the molecular complexity of disease. This provides an unmatched platform to deliver the next generation of precision medicine tools for early detection, diagnosis, monitoring, therapy selection and drug development. To learn more, please visit CarisLifeSciences.com.

Castle Biosciences is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients and providers. The Company’s innovative portfolio of commercial and pipeline tests targets unmet clinical need along the patient care continuum. Castle currently markets six proprietary tests designed to answer clinical questions and address treatment plan challenges facing physicians in dermatologic cancers, Barrett’s esophagus, mental health and uveal melanoma.

Cleveland Clinic Laboratories, led by a team of expert physicians and staff, delivers unparalleled diagnostic services through subspecialized expertise and integrated, best-practice approaches. Our team includes over 100 board-certified anatomic and clinical pathologists, alongside highly skilled medical technologists and laboratory technicians, ensuring precision in every test result and diagnosis.

Offering a comprehensive range of tests from a centralized location, we maintain quick turnaround times and specimen integrity. Centralized data, accessible support, and strong collaboration between the laboratory and ordering providers streamline the diagnostic process, reducing time to diagnosis and treatment for patients worldwide.

Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in more than 30 countries/regions around the world. With more than 120 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients. Through the outstanding knowledge and commitment of our 19,000 + employees worldwide, we create innovative new and generic medicines, and new methods of drug discovery and delivery. We share a passion for innovation, as well as compassion for the patients around the world who are in need of our medicines.

Future-proof your lab's cassette printing with the LaserTrack FLEX cassette printer from General Data Healthcare. The LaserTrack FLEX offers different options - including printing on one to three sides of the cassette - customized to your lab's needs. The FLEX can be upgraded without sacrificing functionality or replacing the printer. General Data’s histology and lab sciences solutions include everything your lab needs for increased operational efficiency, reliable identification, advanced patient safety and highly accurate results.

Passionate about advancing cancer diagnostics, GoPath Diagnostics is a leading full-service laboratory specializing in cancer genetics, molecular, and anatomic pathology. Our cutting-edge technologies, global partnerships, and innovative solutions—GeneticsNow, OncoTarget, and OncoTracking—empower healthcare decisions. Proudly based in Buffalo Grove, IL, our comprehensive services encompass IHC, FISH, PCR testing, flow cytometry, cytogenetics, micro-array, and NGS. Join us in the fight against cancer!

With years of experience operating, managing, building, and owning laboratories, Hankins Consulting knows how to generate revenue and optimize workflow to reach your goals. 

Take advantage of a range of services, including complete turnkey lab build-out solutions, lab management and consulting, staff acquisitions, licensing, RCM and billing, and compliance services. Our goal is to provide clients with solutions that maximize profitability, patient care, and, ultimately, their work/life balance.

Interpace Diagnostics®, LLC is a subsidiary of Interpace Biosciences and is a fully integrated commercial and bioinformatics company that provides evidence-based, clinically beneficial molecular diagnostic tests and pathology services. Interpace Diagnostics develops and commercializes molecular diagnostic tests that deliver cutting-edge genetic and mutational analysis that help risk-stratify patient samples for thyroid, pancreatic, lung, and other cancers to better inform treatment decisions. 

From screening and diagnosis through treatment and remission, Labcorp Oncology has the combined capabilities in diagnostic testing and comprehensive drug development laboratory services to help deliver targeted oncology solutions. We help you navigate the complex treatment landscape, connecting insights from patients, clinical trials, health systems and managed care partners to power better decisions and improve patient outcomes across the cancer care spectrum.

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.

A full service outsourcing medical billing company for hospital based Pathologists.

At Merck, our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer.  The potential to bring new hope to people with cancer drives our purpose and our commitment.  As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry across more than 30 tumor types. 

MLabs is a full-service reference laboratory at Michigan Medicine, providing expert services and rapid turnaround times to physicians nationally and internationally. We specialize in cutting-edge molecular tests for diagnoses, therapeutic evaluations and residual disease monitoring. Our disease-specific service lines include a comprehensive array of single gene assays and next generation sequencing panels. Working with some of the world’s strongest diagnostic pathologists, scientists and geneticists at MLabs, we provide consultative services for challenging cases in all subspecialities. CLIA-certified/CAP-accredited, MLabs has 35+ years of extensive experience and offers personalized service with cost-effective and expert quality laboratory results.For pathology consultations, visit http://mlabs.umich.edu.

MSN’s Pathology Solutions Team has more than 20 years of pathology billing experience working with hospital-based practices and outreach facilities.  We balance the skills and understanding of our expert billing staff with excellent technology – a combination resulting in diligent claims follow-up and collection activity for our pathology clients.  MSN is passionate about client service, and we build strong partnerships with the pathology groups we serve.  We are dedicated to becoming one of the leading pathology billing companies in the country.

As a leader in oncology diagnostics, we provide an extensive range of over 500 tests covering all major testing modalities, including single-gene molecular testing, immunohistochemistry (IHC), flow cytometry, fluorescence in situ hybridization (FISH), DNA- and RNA-based next-generation sequencing (NGS), and comprehensive genomic profiling (CGP). Whether it’s for solid tumors or hematologic cancers, we offer advanced tissue-based, liquid biopsy, and heme tests to deliver precise and actionable insights for personalized care.

We develop high-impact therapies for devastating rare diseases. At Recordati, we focus on the few- those affected by rare diseases. They are our top priority and at the core of everything we do.

Roche provides innovative diagnostic solutions to increase productivity in pathology labs and to
help healthcare providers make faster, more confident decisions. Our portfolio includes
automated slide staining and state of the art sample tracking, a broad menu of diagnostic
assays, and digital pathology solutions. We partner with our customers to improve workflow
efficiency, deliver enhanced medical value, and ensure safety for both the user and the patient

Sonic healthcare represents Thyroseq and NGS molecular test for indeterminate FNAs.

Next Generation Sequencing for Rapid Oncology Testing

Consultation Services for University of Miami.

Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. We collaborate closely with physicians and researchers to identify unmet needs that stand in the way of better care. And then, we find the answers.

Our high-performing tests enable clinicians to make more confident diagnostic, prognostic and treatment decisions for challenging diseases. These include thyroid, prostate, breast, bladder and lung cancers, as well as interstitial lung diseases. We help patients avoid unnecessary procedures and speed time to diagnosis and appropriate treatment.

Our tests are available in the US through our central laboratories. We are also making our tests accessible to patients worldwide through other laboratories that can perform them locally.

Our Vision is to be recognized as a preeminent physician-led pathology practice and laboratory that serves the needs of its patients and business partners. To accomplish this mission, Vitro Molecular Laboratories fosters a workplace environment in which innovation, dedication, collaboration, and professionalism are recognized and rewarded so as to promote a sense of pride, accomplishment and overall empowering of the employees.